City of Hope | Chief of Hematology | Zion, IL
| Company/Institution: |
City of Hope |
| Department: |
Department of Hematology & Hematopoietic Cell Transplantation |
| Location: |
Zion, IL, USA |
| Degree Requirements: |
MD, DO, Board Eligible, Board Certified |
Salary: |
$300,000 or above |
| Job Type: |
Patient Care |
Posted: |
June 3, 2025 |
| Job Setting: |
Hospital/Clinical Facility |
Application Period: |
June 3-August 3, 2025 |
City of Hope Chicago (Zion) has launched a national search for a Board-Certified Hematologist to join our esteemed Chicago team in Zion, IL. The Chief of Hematology will provide leadership to our department of Hematology in clinical, research, and education areas. The Chief will be a highly regarded physician with a collaborative, team-based leadership style, and the ability to leverage and grow our existing, nationally recognized Hematology program. The Chief must also be operationally savvy, with the business acumen and cultural sensitivity to lead within a complex, matrixed organization.
-
This is a clinically focused staff position and applicants with significant experience in the treatment of Lymphoid malignancies, Leukemias (Chronic and Acute), or Plasma Cell Disorders (Myeloma) is highly desired.
COMPETITIVE COMPENSATION:
-
Base Salary Range: $500K to $600K. The range listed is exclusively for base compensation for full-time employment and does not include incentive compensation or benefits. Actual compensation will be adjusted for experience, training, hospital/community need and other factors.
-
Medical/Dental/Vision Plans, Health Savings/Flexible Spending Accounts, Disability, Long-term Care, Life and AD&D, 401(k) Retirement Plan, PTO Paid Plan, Paid malpractice coverage, Professional expense reimbursement.
City of Hope is an equal opportunity employer.
About the Employer
City of Hope is an independent biomedical research and treatment organization for cancer, diabetes and other life-threatening diseases.
Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope, a subsidiary launched in 2019 serves employers and their health care partners by providing access to City of Hope’s specialized cancer expertise.
A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s "Best Hospitals" in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California, Arizona, Illinois and Georgia.
Contact Information
Gleason Daniel
2520 Elisha Avenue
Zion, IL 60099 USA
gdaniel@coh.org
back to top